Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, Leiden Bio Science Park, the ...

Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

The menopausal transition is a pivotal time in women’s health, bringing about profound hormonal, metabolic and physiologic ...

How I Met Your Mother' co-creator Craig Thomas highlights family, disability and representation in debut novel, 'That's Not How It Happened' ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Have you evaluated the performance of Eli Lilly's (LLY) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of this drugmaker, ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the third quarter ended September 30, 2025, ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The Rise Of GLP-1 Drugs In just three years, drugs like Ozempic have reshaped how society views the body. They reignited a ...